Tracking temporal shifts of peripheral blood NLR, PLR, and ALB: a prognostic tool for PD-1 inhibitor efficacy in advanced malignant melanoma
Dynamic monitoring of peripheral blood NLR, PLR, and ALB provides critical insights for predicting PD-1 immunotherapy efficacy in patients with advanced malignant melanoma. These indicators hold promise as potential clinical biomarkers to guide the development of individualized treatment strategies.
Authors
- Fang Wang (ORCID: https://orcid.org/0000-0002-5971-2622)
- Xiangrui Meng (ORCID: https://orcid.org/0000-0001-5058-8701)
- Jiaxin Pei (ORCID: https://orcid.org/0000-0003-2123-0457)
- Yikai Han (ORCID: https://orcid.org/0000-0003-0363-4810)
- Taiying Lu
- Mengmeng Yang
- Ziyi Xiao
- Yushu Deng
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fonc.2025.1704359
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Zhengzhou University